View Older Stories View More Recent Stories

Dec 8, 2022 04:03PM Autolus Announces Proposed Public Offering in the United States
Dec 5, 2022 05:31PM Saratoga Investment Corp. Prices Public Offering of $52.5 Million 8.125% Notes Due 2027
Dec 5, 2022 05:31PM Saratoga Investment Corp. Prices Public Offering of $52.5 Million 8.125% Notes Due 2027
Dec 5, 2022 07:57AM Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Dec 5, 2022 07:57AM Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Dec 1, 2022 11:32AM First Women’s Bank announces new Mission Partners Airbnb, BCG, Principal®, Salesforce and Envestnet have joined the Bank to help close the gender gap in access to capital
Nov 30, 2022 09:30AM William Blair on Wayfair (W): 'Early Signs of Strong Holiday Demand Suggests Upside in the Upcoming Fourth Quarter'
Nov 25, 2022 01:59PM Form 497K WILLIAM BLAIR FUNDS
Nov 25, 2022 01:56PM Form 497K WILLIAM BLAIR FUNDS
Nov 25, 2022 01:53PM Form 497 WILLIAM BLAIR FUNDS
Nov 25, 2022 07:41AM William Blair Reiterates Outperform Rating on Gogo (GOGO) as Business Jet Traffic Hits a Five-Month High
Nov 23, 2022 08:03AM NewAmsterdam Pharma (NAMS) Debuts as Publicly Traded Company
Nov 23, 2022 08:00AM NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential
Nov 23, 2022 08:00AM NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential
Nov 22, 2022 07:08AM William Blair Upgrades Neogen (NEOG) to Outperform
Nov 21, 2022 04:01PM Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:03PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:01PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:01PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:01PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2022 12:01PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 17, 2022 05:57AM Privia Health Group, Inc (PRVA) Prices 5M Share Secondary Offering at $23.50/sh
Nov 17, 2022 05:50AM Biodesix (BDSX) Prices Upsized 30.5M Share Offering at $1.15/sh
Nov 17, 2022 12:26AM Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock
Nov 16, 2022 08:22PM Privia Health Announces Pricing of Secondary Offering
Nov 16, 2022 04:06PM Biodesix Inc. (BDSX) Announces Proposed $30M Stock Offering
Nov 16, 2022 04:05PM Biodesix Announces Proposed Public Offering of Common Stock
Nov 16, 2022 11:00AM Millennium Trust Names Dan Laszlo Chief Executive Officer
Nov 15, 2022 04:41PM Privia Health Group (PRVA) Announces 5M Share Secondary Offering by Selling Stockholders
Nov 15, 2022 04:40PM Privia Health Announces Secondary Offering
Nov 15, 2022 12:04PM Clarivate (CLVT) gains on new Elliott stake, but change is already taking place
Nov 15, 2022 11:31AM Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.
Nov 14, 2022 01:22PM Palantir (PLTR) investors missed Fast Radius bankruptcy news - William Blair
Nov 14, 2022 09:18AM UPDATE: William Blair Starts Janux Therapeutics (JANX) at Outperform
Nov 14, 2022 09:17AM William Blair Downgrades Science 37 (SNCE) to Market Perform
Nov 14, 2022 09:15AM William Blair Starts Genmab A/S (GMAB) at Market Perform
View More Recent Stories View Older Stories